Monographie - Mycophenolate mofetil - Stabilis 4.0

Poslední aktualizace :
28/04/2024

Imunosupresivum

Mycophenolate mofetil

Injekce

Perorální roztok

Stabilita roztoků

Stabilita směsí

Faktory ovlivňující stabilitu

Kompatibilita

Způsoby aplikace

Odkazy

Pdf

Chemický vzorec

Obchodní název

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cellcept	äpanÏlsko, Austrálie, Dánsko, Finsko, Francie, Irsko, Itálie, Japonsko, Kanada, Kolumbie, Lucembursko, MaÔarsko, Mexiko, NÏmecko, Nizozemsko, Norsko, Nový Zéland, Polsko, Portugalsko, Rakousko, Švédsko, Švýcarsko, USA, Velká Británie, ÿecko
Micofenolato de mofetilo	äpanÏlsko
Mycophenolate mofetil	Belgie, NÏmecko, Velká Británie

Odkazy

Injekce

Odkazy : Mycophenolate mofetil

	Typ	Uveřejnění
1981	Noviny	Certain E, Beteta F, Goudou-Sinha C, Darbord JC, Prognon P, Jacquot C. Stability of i.v. mycophenolate mofetil in 5% dextrose injection in polyvinyl chloride infusion bags. Am J Health-Syst Pharm 2002 ; 59: 2434-2439.
1982	Noviny	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2108	Noviny	Trusley C, Kupiec TC, Trissel LA. Compatibility of micafungin injection with other drugs during simulated Y-site co-administration. Int J Pharm Compound 2006 ; 10: 230-232.
2192	Noviny	Cochran BG, Sowinski KM, Fausel C, Overholser BR. Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs. Am J Health-Syst Pharm 2007 ; 64, 13: 1410-1414.
2247	Noviny	Chan P, Heatherly K, Kupiec T.C, Trissel L.A. Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2008 ; 12, 3: 276-278.
3728	Noviny	Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3828	Plakát	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	Plakát	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	Noviny	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4299	Noviny	Ezquer-Garin C, Ferriols-Lisart R, Alos-Alminana M. Stability of mycophenolate mofetil in polypropylene 5% dextrose infusion bags and chemical compatibility associated with the use of the EQUASHIELD® closed-system transfer device. Biomed Chromatogr 2019 ; 33, 7: e4529.
4528	Noviny	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4698	Noviny	Ayari G, D'Huart E, Vigneron J, Demoré B. Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs. Pharmaceutical Technology in Hospital Pharmacy 2022

Mentions Légales